Importantly, the percentage (23.5%) of SDHA-high PDX tumors in our data set is consistent with the percentage (19%) of ovarian tumors harboring amplification and/or overexpression of SDHA in patients population (TGCA data set) [24]. The gene discussed is SDHA; the disease is ovarian neoplasm.